Contact with Local Pharmaceutical Companies

In order to get a clearer picture of UDCA-contained drug’s manufacturing circumstance in China, our team visited Tianjin Pacific Chemical & Pharmaceutical Company to interview the experts about current chemical producing methods. According to Mr. Xing Ruwen and Mr. Li Jinlong, the most popular method of producing UDCA-contained medicine in the market mainly focuses on chemical pharmaceutical procedures. Yet this approach has disadvantages including relatively weak efficacy and potential harm to health of the workers. He praises our aim to produce UDCA medic in biopharmaceutical procedure and consider it very promising. Furthermore, he encouraged us to cut off cost so that our method can be accepted by the market and the patients. This suggestion helped us to clarify our future goal.

Mr. Xing Ruwen

Mr. Xing Ruwen is the chief engineer in Tianjin Pacific Chemical & Pharmaceutical Company. He is an experienced manager who has been working on Chemical method of producing UDCA-contained drugs for years.

Mr. Xing introduces us the traditional chemical procedure to manufacture the UDCA-contained drug. Also, he leads us to visit the processing workshop and teaches us many valuable knowledge about drug production.

According to his opinion, chemical method of producing UDCA-contained drug basically has two disadvantages: the first one is its high risk; the second one is related to profit, a factor that influences manufacturing the most. For its potential high risk, Mr. Xing conveys that it comes from the utilization of metal sodium. Sodium is well-known for its highly-reactiveness; it is able react violently with water, which at the same time release large amount of heat and might cause potential safety issue to the workers. He praises our thought of avoiding the dangerousness and very much acknowledges our method.

Mr. Li Jinlong

Mr. Li Jinlong works as the production manager and he also participating in marketing department’s work in Tianjin Pacific Chemical & Pharmaceutical Company.

Mr. Li patiently answers our questions related to marketing. Analyzing its cost, demand and also profit, Mr. Li helps us to determined our minds on trying to solve the problem step by step. He informs that currently the successful UDCA synthesis rate is not hight enough and requires repeating measures to increase its purification ratio. It is very important for us to consider more about the balance between cost and profits if we want to further develop our method. Now, the exported UDCA drugs are highly demanded and we need to find ways to help simplify the production process and to increase the supply of UDCA-contained drugs.